logo

4.41

4.41 (-0.59%)

As of Mar 06, 2024

Omeros Corp [OMER]

Source: 

Company Overview

Omeros Corp is a clinical-stage biopharmaceutical company committed to discovering, developing and commercializing small-molecule and protein therapeutics for large-market as well as orphan indications targeting immunologic disorders including complement-mediated diseases, cancers, and addictive and compulsive disorders.

CountryUnited States
Headquartersseattlewashington
Phone Number206-676-5000
Industry
manufacturing
CEOGregory A. Demopulos
Websitewww.omeros.com